Metals and metal compounds in carcinogenesis

Area of Science:

• Environmental toxicology
• Molecular carcinogenesis
• Metal-induced toxicity

Background:

• Certain metals and metal compounds are recognized as significant mutagens and carcinogens.
• Chromium, arsenic, nickel, vanadium, iron, copper, and manganese are frequently implicated in such effects.

Purpose of the Study:

• To explore the mechanisms by which metals induce mutagenicity and carcinogenicity.
• To highlight the dual role of certain metals, such as arsenic, in both causing and treating cancer.

Main Methods:

• Review of existing literature on metal toxicity and carcinogenicity.
• Analysis of proposed mechanisms involving reactive oxygen species (ROS).
• Examination of specific metal effects, including nickel's modulation of gene expression and arsenic's impact on cell metabolism.

Main Results:

• Most metal-induced mechanisms are believed to involve reactive oxygen species (ROS).
• Nickel can alter gene expression through DNA methylation and histone acetylation changes.
• Long-term, low-level arsenic exposure may induce cell transformation, yet arsenic also possesses anti-cancer therapeutic properties.
• Manganese can cause DNA damage but has a low carcinogenic risk; magnesium deficiency and iron excess are linked to cancer risk.

Conclusions:

• Metals play a complex role in carcinogenesis, with diverse mechanisms.
• Understanding these mechanisms is crucial for both prevention and therapeutic strategies.
• The dual nature of some metals, like arsenic, warrants further investigation for cancer treatment applications.